01:29 PM EST - The Yield Growth Corp. : Subsidiary Flourish Mushroom Labs Inc. announced that it signed a non binding letter of intent with Kingdom Brands Management Inc. on February 12, 2020. Per the LOI, Kingdom will pay $500,000 to Flourish in exchange for the rights to use and sub-license in the United States, Yield Growth's proprietary extraction technology for use exclusively with both medicinal and psychedelic mushrooms and to further develop the technology. "The Yield Growth Corp. previously engaged a high-quality, accredited lab to identify and quantify targeted therapeutic compounds found in the hemp root. We successfully sequestered one of these compounds, Friedelin, at a higher concentration compared to other extraction methods, using our technology," said Penny White, CEO of The Yield Growth Corp. and Flourish Mushroom Labs. "We are now licensing this technology for Flourish Mushroom Labs to aid in cell disruption of mushrooms in order to extract the therapeutic compounds more efficiently." The Yield Growth Corp.
shares BOSS:CNX are trading off 1.89 percent at $0.26.
